{"id":55681,"date":"2025-11-06T16:08:32","date_gmt":"2025-11-06T20:08:32","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/pharma-giants-strike-landmark-deals-boeing-secures-major-order-and-ford-adjusts-ev-strategy-amid-market-shifts\/55681\/"},"modified":"2025-11-06T16:08:32","modified_gmt":"2025-11-06T20:08:32","slug":"pharma-giants-strike-landmark-deals-boeing-secures-major-order-and-ford-adjusts-ev-strategy-amid-market-shifts","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/pharma-giants-strike-landmark-deals-boeing-secures-major-order-and-ford-adjusts-ev-strategy-amid-market-shifts\/55681\/","title":{"rendered":"Pharma Giants Strike Landmark Deals, Boeing Secures Major Order, and Ford Adjusts EV Strategy Amid Market Shifts"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Eli Lilly<\/strong> (<a href=\"\/stock\/LLY\">LLY<\/a>) and <strong>Novo Nordisk<\/strong> (<a href=\"\/stock\/NVO\">NVO<\/a>) are nearing landmark deals with the U.S. government to significantly expand access to their leading obesity drugs, <strong>Zepbound<\/strong> and <strong>Wegovy<\/strong>, potentially offering treatments for Medicare patients at <strong>$149-$299 per month<\/strong> and accelerating FDA review for new therapies.<\/li>\n<li>The <strong><a href=\"https:\/\/thestockmarketwatch.com\/live\/trump-stock-market\" data-internallinksmanager029f6b8e52c=\"8\" title=\"Trump\">Trump<\/a> administration<\/strong> is poised to announce major international trade agreements, including an <strong>$8 billion+ order<\/strong> for up to <strong>22 Boeing 787 Dreamliners<\/strong> by <strong>Uzbekistan Airways<\/strong>, a deal projected to support nearly <strong>35,000 U.S. jobs<\/strong>.<\/li>\n<li><strong>Novo Nordisk&#39;s<\/strong> investigational obesity drug, <strong>Cagrisema<\/strong>, demonstrated a nearly <strong>70% reduction<\/strong> in a key inflammatory marker associated with increased cardiovascular risk and a <strong>10.9 mmHg reduction<\/strong> in systolic blood pressure in its Phase 3 REDEFINE 1 trial.<\/li>\n<li><strong>Ford<\/strong> (<a href=\"\/stock\/F\">F<\/a>) is reportedly halting production of its <strong>F-150 Lightning<\/strong> electric pickup for several weeks due to softening demand, following a <strong>$1.2 billion quarterly loss<\/strong> in its EV division.<\/li>\n<li><strong>OpenAI<\/strong> CEO <strong>Sam Altman<\/strong> is actively seeking &quot;trillions&quot; of dollars to fund a global network of AI chip fabrication plants, while U.S. crude oil futures settled at <strong>$59.43\/bbl<\/strong>, down <strong>0.29%<\/strong>.<\/li>\n<\/ul>\n<h2>Pharmaceutical Sector Sees Major Developments<\/h2>\n<p>The pharmaceutical industry is buzzing with significant news, particularly concerning obesity treatments. <strong>Eli Lilly<\/strong> (<a href=\"\/stock\/LLY\">LLY<\/a>) and <strong>Novo Nordisk<\/strong> (<a href=\"\/stock\/NVO\">NVO<\/a>), key players in the weight-loss drug market, are reportedly close to finalizing deals with the <strong><a href=\"https:\/\/thestockmarketwatch.com\/live\/trump-stock-market\" data-internallinksmanager029f6b8e52c=\"8\" title=\"Trump\">Trump<\/a> administration<\/strong> to broaden access to their highly sought-after medications. These agreements could see the lowest doses of <strong>Eli Lilly&#39;s Zepbound<\/strong> (tirzepatide) offered for <strong>$299 per month<\/strong> and its experimental oral drug <strong>orforglipron<\/strong> for <strong>$149 per month<\/strong> through the TrumpRx initiative for Medicare patients. The negotiations also involve a push for priority FDA approval for <strong>Lilly&#39;s<\/strong> new treatments.<\/p>\n<p>Meanwhile, <strong>Novo Nordisk<\/strong> (<a href=\"\/stock\/NVO\">NVO<\/a>) has announced positive results for its investigational injectable combination treatment, <strong>Cagrisema<\/strong>. New post hoc analyses from the Phase 3 REDEFINE 1 trial revealed a nearly <strong>70% reduction<\/strong> in a key inflammatory marker linked to increased cardiovascular risk. The drug also showed a <strong>10.9 mmHg reduction<\/strong> in systolic blood pressure over 68 weeks, enabling approximately <strong>40% of patients<\/strong> on blood pressure medication to reduce or discontinue their treatment. These findings were presented at ObesityWeek, highlighting <strong>Cagrisema&#39;s<\/strong> potential to address both weight and cardiovascular health in adults with overweight or obesity.<\/p>\n<h2>Aerospace and Trade: Boeing Secures Central Asian Deals<\/h2>\n<p>The <strong>Trump administration<\/strong> is preparing to announce substantial international trade agreements, with <strong>Boeing<\/strong> (<a href=\"\/stock\/BA\">BA<\/a>) at the forefront. <strong>Uzbekistan Airways<\/strong> has committed to purchasing up to <strong>22 Boeing 787 Dreamliners<\/strong> (14 firm orders with options for 8 more) in a deal valued at over <strong>$8 billion<\/strong>. This agreement, hailed by the U.S. Commerce Department as the &quot;largest commercial aircraft agreement of its kind in Central Asia,&quot; is expected to generate nearly <strong>35,000 U.S. jobs<\/strong>. Additionally, <strong>Kazakhstan<\/strong> has finalized a <strong>$4.2 billion<\/strong> deal to acquire 300 freight locomotives from <strong>Wabtec Corporation<\/strong>, further solidifying U.S. trade ties in the region.<\/p>\n<h2>Automotive Shift: Ford Reconsiders EV Strategy<\/h2>\n<p>In the automotive sector, <strong>Ford<\/strong> (<a href=\"\/stock\/F\">F<\/a>) is reportedly adjusting its electric vehicle production strategy. The company is expected to halt production of its <strong>F-150 Lightning<\/strong> electric pickup truck for several weeks, from mid-November through January 6, citing softening demand. This move follows a challenging period for <strong>Ford&#39;s<\/strong> EV division, <strong>Ford Model e<\/strong>, which recorded a <strong>$1.2 billion loss<\/strong> in the third quarter, with revenue declining by a third year-over-year. Production of the <strong>F-150 Lightning<\/strong> had already been scaled back earlier in the year, and <strong>Ford<\/strong> has also halved its 2024 production targets for the electric truck.<\/p>\n<h2>Tech and Energy Updates<\/h2>\n<p><strong>OpenAI<\/strong> CEO <strong>Sam Altman<\/strong> is reportedly embarking on an ambitious fundraising initiative, seeking &quot;trillions&quot; of dollars to establish a global network of AI chip fabrication plants. Altman has engaged with various investors, including those from the UAE and <strong>Softbank<\/strong>, as well as major chipmakers like <strong>TSMC<\/strong>, to address the critical scarcity of AI chips. He has discussed securing loan guarantees for these chip fabs, but not for <strong>OpenAI&#39;s<\/strong> own datacenters, with the entire venture requiring U.S. government approval due to potential national security and antitrust implications.<\/p>\n<p>In energy markets, U.S. crude oil futures settled at <strong>$59.43 per barrel<\/strong>, marking a slight decrease of <strong>17 cents<\/strong> or <strong>0.29%<\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Eli Lilly (LLY) and Novo Nordisk (NVO) are nearing landmark deals with the U.S. government to significantly expand [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[5317,337,5349,3703,5633,3744,5775,3754,6334,3767,6761,4461,4832,5024,5189],"class_list":["post-55681","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-openai","tag-lly","tag-aerospace","tag-ai","tag-ford","tag-nvo","tag-pharmaceuticals","tag-f","tag-novo-nordisk","tag-ba","tag-eli-lilly","tag-crude-oil","tag-electric-vehicles","tag-trade","tag-boeing"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/55681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=55681"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/55681\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=55681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=55681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=55681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}